Seres Therapeutics shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Seres Therapeutics (MCRB) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Seres Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Seres Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Seres Therapeutics by Rhumbline Advisers
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $193k | 138k | 1.40 |
2023-09-30 | $325k | 137k | 2.38 |
2023-06-30 | $646k | 135k | 4.79 |
2023-03-31 | $535k | 94k | 5.67 |
2022-12-31 | $502k | 90k | 5.60 |
2022-09-30 | $564k | 88k | 6.41 |
2022-06-30 | $269k | 79k | 3.43 |
2022-03-31 | $588k | 83k | 7.12 |
2021-12-31 | $689k | 83k | 8.33 |
2021-09-30 | $568k | 82k | 6.96 |
2021-06-30 | $1.9M | 79k | 23.86 |
2021-03-31 | $1.5M | 71k | 20.59 |
2020-12-31 | $1.9M | 76k | 24.50 |
2020-09-30 | $1.9M | 66k | 28.32 |
2020-06-30 | $267k | 56k | 4.76 |
2020-03-31 | $164k | 46k | 3.57 |
2019-12-31 | $158k | 46k | 3.44 |
2019-09-30 | $170k | 42k | 4.01 |
2019-06-30 | $119k | 37k | 3.23 |
2019-03-31 | $185k | 27k | 6.88 |
2018-12-31 | $123k | 27k | 4.53 |
2018-09-30 | $138k | 18k | 7.57 |
2018-06-30 | $168k | 20k | 8.59 |
2018-03-31 | $137k | 19k | 7.32 |
2017-12-31 | $194k | 19k | 10.16 |
2017-09-30 | $365k | 23k | 16.03 |
2017-06-30 | $254k | 23k | 11.30 |
2017-03-31 | $221k | 20k | 11.29 |
2016-12-31 | $188k | 19k | 9.89 |
2016-09-30 | $193k | 16k | 12.27 |
2016-06-30 | $448k | 15k | 29.03 |
2016-03-31 | $220k | 8.3k | 26.62 |
2015-12-31 | $271k | 7.7k | 35.08 |